Nichols Weston 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Jun 21, 2023
Insider Transaction Report
Form 4
Nichols Weston
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-16+17,500→ 17,500 totalExercise: $20.32Exp: 2033-06-15→ Common Stock (17,500 underlying) - Award
Common Stock
2023-06-16+6,000→ 6,000 total
Footnotes (2)
- [F1]The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
- [F2]The stock option shall vest and become exercisable on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.